{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T01:31:57Z","timestamp":1776389517861,"version":"3.51.2"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1053\/j.seminhematol.2024.11.001","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T18:37:46Z","timestamp":1732127866000},"page":"465-469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Management of Myelodysplastic Syndrome in Pregnant Patients: Treatment Approaches and Considerations"],"prefix":"10.1053","volume":"61","author":[{"given":"Erin","family":"McDonald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6102-1695","authenticated-orcid":false,"given":"David M.","family":"Swoboda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1053\/j.seminhematol.2024.11.001_bib0001","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World health organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.11.001_bib0002","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3324\/haematol.2017.165993","article-title":"Myelodysplasia in younger adults: outlier or unique molecular entity?","volume":"102","author":"Sallman","year":"2017","journal-title":"Haematologica"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.11.001_bib0003","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0145-2126(01)00125-4","article-title":"Successful management and perinatal outcome of pregnancy complicated with myelodysplastic syndrome","volume":"26","author":"Ikeda","year":"2002","journal-title":"Leuk Res"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.11.001_bib0004","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1080\/10428190127512","article-title":"Myelodysplastic syndrome and pregnancy: the Mayo Clinic experience","volume":"42","author":"Steensma","year":"2001","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.11.001_bib0005","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/ccr3.3935","article-title":"Labor induction in pregnancy complicated by myelodysplastic syndrome: A case report","volume":"9","author":"Peng","year":"2021","journal-title":"Clin Case Rep"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.11.001_bib0006","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/1097-0142(19900715)66:2<377::AID-CNCR2820660230>3.0.CO;2-Q","article-title":"Myelodysplastic syndromes presenting in pregnancy. A report of five cases and the clinical outcome","volume":"66","author":"Siddiqui","year":"1990","journal-title":"Cancer"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.11.001_bib0007","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.leukres.2008.06.035","article-title":"Myelodysplastic syndrome and pregnancy: case report","volume":"33","author":"Sackmann Massa","year":"2009","journal-title":"Leuk Res"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.11.001_bib0008","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood.2020004850","article-title":"SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS","volume":"136","author":"Malcovati","year":"2020","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.11.001_bib0009","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1182\/blood-2015-03-633537","article-title":"SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts","volume":"126","author":"Malcovati","year":"2015","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.seminhematol.2024.11.001_bib0010","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.seminhematol.2024.11.001_bib0011","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200008","article-title":"Molecular international prognostic scoring system for myelodysplastic syndromes","volume":"1","author":"Bernard","year":"2022","journal-title":"NEJM Evid"},{"issue":"10","key":"10.1053\/j.seminhematol.2024.11.001_bib0012","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1182\/blood-2018-10-844696","article-title":"Treatment of MDS","volume":"133","author":"Platzbecker","year":"2019","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminhematol.2024.11.001_bib0013","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.leukres.2008.02.006","article-title":"Pregnancy in patients with myelodysplastic syndromes (MDS)","volume":"32","author":"Volpicelli","year":"2008","journal-title":"Leuk Res"},{"key":"10.1053\/j.seminhematol.2024.11.001_bib0014","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.2000.tb06223.x","article-title":"Pharmakides G. Anemia in pregnancy","volume":"900","author":"Sifakis","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1053\/j.seminhematol.2024.11.001_bib0015","unstructured":"Megan Lord M. Blood transfusion in obstetric patients 2023 Available from: https:\/\/www.exxcellence.org\/list-of-pearls\/blood-transfusion-in-obstetric-patients\/?categoryName=&searchTerms=&featured=False&bookmarked=False&sortColumn=date&sortDirection=Descending#:\u223c:text=Most%20blood%20transfusions%20in%20pregnancy,third%20trimester%2C%20from%20peripartum%20hemorrhages."},{"issue":"233","key":"10.1053\/j.seminhematol.2024.11.001_bib0016","first-page":"72063","article-title":"Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final rule","volume":"79","year":"2014","journal-title":"Fed Regist"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.11.001_bib0017","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/sj.bjc.6600503","article-title":"Differences in efficacy found in animals between recombinant forms of erythropoietin will not necessarily translate into differences in humans","volume":"87","author":"Malonne","year":"2002","journal-title":"Br J Cancer"},{"issue":"10399","key":"10.1053\/j.seminhematol.2024.11.001_bib0018","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0140-6736(23)00874-7","article-title":"Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial","volume":"402","author":"Platzbecker","year":"2023","journal-title":"Lancet"},{"issue":"8","key":"10.1053\/j.seminhematol.2024.11.001_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16081462","article-title":"The Challenge for a Correct Diagnosis of Refractory Thrombocytopenia: ITP or MDS with Isolated Thrombocytopenia?","volume":"16","author":"Kosmidou","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.11.001_bib0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1182\/blood-2012-08-448944","article-title":"Stasi R. How I treat thrombocytopenia in pregnancy","volume":"121","author":"Gernsheimer","year":"2013","journal-title":"Blood"},{"issue":"21","key":"10.1053\/j.seminhematol.2024.11.001_bib0021","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1182\/blood-2017-05-781971","article-title":"Thrombocytopenia in pregnancy","volume":"130","author":"Cines","year":"2017","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.11.001_bib0022","first-page":"95","article-title":"Platelet function in the myelodysplastic syndromes","volume":"71","author":"Mittelman","year":"2000","journal-title":"Int J Hematol"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.11.001_bib0023","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/ajcp\/91.6.647","article-title":"Platelet function and structure in myeloproliferative disease, myelodysplastic syndrome, and secondary thrombocytosis","volume":"91","author":"Raman","year":"1989","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.11.001_bib0024","first-page":"55","article-title":"Thrombocytopenia in Pregnancy","volume":"11","author":"Ciobanu","year":"2016","journal-title":"Maedica (Bucur)."},{"issue":"3","key":"10.1053\/j.seminhematol.2024.11.001_bib0025","doi-asserted-by":"crossref","first-page":"B25","DOI":"10.1016\/j.ajog.2022.07.022","article-title":"Obstetric care consensus #11, pregnancy at age 35 years or older","volume":"228","author":"Gantt","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1053\/j.seminhematol.2024.11.001_bib0026","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2018-10-844662","article-title":"Genetic predisposition to MDS: clinical features and clonal evolution","volume":"133","author":"Kennedy","year":"2019","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.seminhematol.2024.11.001_bib0027","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1182\/blood-2013-08-283580","article-title":"How I treat leukemia during pregnancy","volume":"123","author":"Milojkovic","year":"2014","journal-title":"Blood"},{"issue":"21","key":"10.1053\/j.seminhematol.2024.11.001_bib0028","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1093\/hmg\/ddm187","article-title":"Aberrant DNA methylation of imprinted loci in sperm from oligospermic patients","volume":"16","author":"Kobayashi","year":"2007","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.11.001_bib0029","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1006\/faat.1994.1124","article-title":"Effect of 5-azacytidine administration during very early pregnancy","volume":"23","author":"Cummings","year":"1994","journal-title":"Fundam Appl Toxicol"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.11.001_bib0030","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.htct.2020.11.004","article-title":"Teratogenic effect of decitabine in a pregnant patient with acute myeloid leukemia: a case report","volume":"44","author":"Lee","year":"2022","journal-title":"Hematol Transfus Cell Ther"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.11.001_bib0031","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/bjh.14417","article-title":"Successful molecular targeted treatment of AML in pregnancy with Azacitidine and Sorafenib with no adverse fetal outcomes","volume":"180","author":"Mahdi","year":"2018","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.11.001_bib0032","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1186\/s12884-019-2522-1","article-title":"The use of 5-azacytidine in pregnant patient with Acute Myeloid Leukemia (AML): a case report","volume":"19","author":"Alrajhi","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"issue":"18","key":"10.1053\/j.seminhematol.2024.11.001_bib0033","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.3109\/14767058.2014.980229","article-title":"Pregnancy and myelodysplastic syndrome: an analysis of the clinical characteristics, maternal and fetal outcomes","volume":"28","author":"Yang","year":"2015","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"9","key":"10.1053\/j.seminhematol.2024.11.001_bib0034","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1182\/blood.2023020726","article-title":"How I treat thrombocytopenia in pregnancy","volume":"143","author":"Fogerty","year":"2024","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.11.001_bib0035","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1186\/s12884-020-03432-7","article-title":"Supportive medication in cancer during pregnancy","volume":"20","author":"Zagouri","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.11.001_bib0036","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1200\/JOP.2015.006742","article-title":"Recommendations for the use of white blood cell growth factors: american society of clinical oncology clinical practice guideline update","volume":"11","author":"Smith","year":"2015","journal-title":"J Oncol Pract"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.11.001_bib0037","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13061214","article-title":"Maternal and neonatal outcome after the use of G-CSF for cancer treatment during pregnancy","volume":"13","author":"Berends","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1053\/j.seminhematol.2024.11.001_bib0038","unstructured":"Ijaz A, Patel P. Thrombopoietin Receptor Agonists. StatPearls. Treasure Island (FL) 2024."},{"issue":"2","key":"10.1053\/j.seminhematol.2024.11.001_bib0039","first-page":"e22505","article-title":"Use of eltrombopag for the first trimester pregnancy complicated with refractory idiopathic thrombocytopenic purpura: a case report and literature review","volume":"14","author":"Shibata","year":"2022","journal-title":"Cureus"},{"issue":"9","key":"10.1053\/j.seminhematol.2024.11.001_bib0040","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1086\/522182","article-title":"Immune reconstitution syndrome and exacerbation of infections after pregnancy","volume":"45","author":"Singh","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.11.001_bib0041","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1182\/blood-2015-01-620872","article-title":"A systematic review of transfusion-associated graft-versus-host disease","volume":"126","author":"Kopolovic","year":"2015","journal-title":"Blood"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196324001288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196324001288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T17:53:20Z","timestamp":1734026000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196324001288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0037196324001288"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2024.11.001","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Myelodysplastic Syndrome in Pregnant Patients: Treatment Approaches and Considerations","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2024.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}